News

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Moderna on Monday said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot in a late-stage trial, clearing a path forward for the product and ...
Moderna stock veered higher Monday after its flu shot proved to be as effective as older technology in a final-phase study.